Skip to main content
. 2011 May 23;10:46. doi: 10.1186/1475-2840-10-46

Table 5.

Estimated Relative Risk (Hazard Ratio) of Death from CVD Among U.S. Adults Aged ≥20 Years with Both Diagnosed Diabetes and Undiagnosed Diabetes (A1C≥6.5%) According to Serum Non-HDL-C Concentrations, the Third National Health and Nutrition Examination Survey Linked Mortality Study, 1988-2006

Cause of death Serum non-HDL-C concentration (mg/dL)
35-129 130-189 190-403 P-valuea
Unadjusted risk estimates
 Total CVD 1 [Ref] 0.93 (0.63-1.38) 1.55 (1.03-2.34) 0.033
 Ischemic heart disease 1 [Ref] 0.87 (0.5-1.51) 1.44 (0.87-2.38) 0.14
 Stroke 1 [Ref] 3.34 (1.17-9.52) 3.87 (1.54-9.76) 0.0033
 Other CVD 1 [Ref] 0.66 (0.32-1.36) 1.42 (0.74-2.71) 0.28
Adjusted risk estimates
 Total CVD 1 [Ref] 0.95 (0.63-1.45) 1.53 (0.95-2.45) 0.072
 Ischemic heart disease 1 [Ref] 0.91 (0.50-1.65) 1.51 (0.88-2.59) 0.13
 Stroke 1 [Ref] 3.44 (1.23-9.63) 4.33 (1.63-11.49) 0.0026
 Other CVD 1 [Ref] 0.58 (0.26-1.31) 1.01 (0.45-2.24) 0.99

Abbreviations: CVD, cardiovascular disease; non-HDL-C, non-high-density lipoprotein cholesterol; Ref, reference value.

a T-tests were used for testing linear trends. Age was the time scale in the Cox proportional hazard regression analyses. Relative risks (hazard ratios) and their 95% CIs were adjusted for sex, race/ethnicity, education attainment, diabetes duration, body mass index, leisure-time physical activity, smoking status, alcohol consumption, systolic blood pressure, serum HDL-C concentration, glomerular filtration rate, C-reactive protein, and self-reported use of prescribed medicine to lower blood cholesterol.

N = 1,647 participants with diagnosed diabetes and undiagnosed diabetes (i.e., glycated hemoglobin A1C ≥ 6.5%).